FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 69 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,091,000 | -2.3% | 217,670 | 0.0% | 0.12% | -17.3% |
Q1 2018 | $1,117,000 | +7.1% | 217,670 | +25.5% | 0.14% | +29.9% |
Q4 2017 | $1,043,000 | +8.3% | 173,501 | 0.0% | 0.11% | -20.1% |
Q3 2017 | $963,000 | +16.9% | 173,501 | -2.2% | 0.13% | +21.8% |
Q2 2017 | $824,000 | +0.6% | 177,488 | +74.5% | 0.11% | -26.7% |
Q1 2017 | $819,000 | – | 101,700 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |